| 1 |
Health Canada Proposes New Maximum Residue Limit for Pydiflumetofen and Difenoconazole
|
Regulatory Regions |
gpcgateway.com |
is proposed extension is to improve the efficacy of the product to control alternaria le |
| 2 |
NMPA published a notification on the enforcement of toothpaste regulation
|
Regulatory Regions |
gpcgateway.com |
re, research data or summary of product efficacy evaluation data on which efficacy claim |
| 3 |
Chile prohibits animal testing for cosmetics
|
Regulatory Regions |
gpcgateway.com |
The use of animals for the safety and efficacy testing of cosmetic, hygiene, and perso |
| 4 |
Brazil's Anvisa publishes rules for paints and varnishes with sanitizing action
|
Regulatory Regions |
gpcgateway.com |
e measures aim to ensure the safety and efficacy of sanitizing paints and varnishes used |
| 5 |
East African countries notify WTO of draft standards for skincare products
|
Regulatory Regions |
gpcgateway.com |
tics, and methods for testing sunscreen efficacy.
Terms and Definitions: Provide |
| 6 |
Indian Government Tightens Regulations for Biostimulants in Agriculture
|
Regulatory Regions |
gpcgateway.com |
omposition, effectiveness on crops (bio-efficacy), and potential risks to the environmen |
| 7 |
NIFDC issues guidelines for Cosmetic Safety Assessment and Data Submission
|
Regulatory Regions |
gpcgateway.com |
cifications".
Products claiming efficacy in acne treatment, anti-wrinkle (exclud |
| 8 |
New Regulation for Hazardous Substances to Take Effect in Peru on June 1 2024
|
Regulatory Regions |
gpcgateway.com |
that only products that meet safety and efficacy standards are available on the market.
|
| 9 |
China Approves New Cosmetic Ingredient for Whitening Products
|
Regulatory Regions |
gpcgateway.com |
ized and has been tested for safety and efficacy. It can be used as a whitening agent in |
| 10 |
Government of India Issues New Circular on Licensing of In Vitro Diagnostic Medical Devices.
|
Regulatory Regions |
gpcgateway.com |
ses and ensure the continued safety and efficacy of medical devices in India.Â
|
| 11 |
EU Moves Ahead with Approval of DBNPA BIT and Formic Acid for Biocidal Products to Improve Safety and Standards
|
Regulatory Regions |
gpcgateway.com |
eservatives. BIT is widely used for its efficacy against bacteria and fungi, making it v |
| 12 |
EPA Finalizes Test Methods for Measuring Disinfectant Residues on Hard Surfaces
|
Regulatory Regions |
gpcgateway.com |
is critical to ensuring the safety and efficacy of disinfectants used in a variety of e |
| 13 |
Chile Publishes Draft Regulations for the Import and Use of Pesticide Samples
|
Regulatory Regions |
gpcgateway.com |
e reports must include data on the use, efficacy and any observed environmental or healt |
| 14 |
EPA Releases User-Friendly Pesticide Concentration Calculator
|
Regulatory Regions |
gpcgateway.com |
and drinking water risks. To ensure the efficacy of the model, EPA will continue to upda |
| 15 |
India publishes new circular on medical devices.
|
Regulatory Regions |
gpcgateway.com |
ential standards of quality, safety and efficacy.Â
Class C & D DevicesÂ
The noti |
| 16 |
EU Notifies WTO of Draft Amendments to Data Requirements for Plant Protection Products
|
Regulatory Regions |
gpcgateway.com |
ed testing and reporting provisions for efficacy, residues, and risk assessments, taking |
| 17 |
Taiwan FDA Releases New Guideline on UV Filters in Cosmetic Products Effective from 1 July 2024
|
Regulatory Regions |
gpcgateway.com |
orting documentation for sun protection efficacy in their product information file.
 |
| 18 |
Japan Adds Cosmetic Ingredients to NITE-CHRIP Database
|
Regulatory Regions |
gpcgateway.com |
ated under the Act on Securing Quality, Efficacy and Safety of Products Including Pharma |
| 19 |
Australia - Key Regulatory Insights 2024
|
Regulatory Regions |
gpcgateway.com |
ensuring higher standards of safety and efficacy for consumers. Key changes include impr |
| 20 |
Paraguay Regulates Hygiene Cosmetic and Perfume Products under Decree No. 2942
|
Regulatory Regions |
gpcgateway.com |
de 2: Products with specific safety and efficacy requirements, requiring a more stringen |